Creative Planning - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 10 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Creative Planning ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q3 2022$10,0000.0%10,0000.0%0.00%
Q2 2022$10,0000.0%10,0000.0%0.00%
Q1 2022$10,0000.0%10,0000.0%0.00%
Q4 2021$10,0000.0%10,0000.0%0.00%
Q3 2021$10,0000.0%10,0000.0%0.00%
Q2 2021$10,0000.0%10,0000.0%0.00%
Q1 2021$10,0000.0%10,0000.0%0.00%
Q4 2020$10,0000.0%10,0000.0%0.00%
Q3 2020$10,0000.0%10,0000.0%0.00%
Q2 2020$10,000
+11.1%
10,0000.0%0.00%
Q1 2020$9,0000.0%10,0000.0%0.00%
Q4 2019$9,0000.0%10,0000.0%0.00%
Q3 2019$9,0000.0%10,0000.0%0.00%
Q2 2019$9,0000.0%10,0000.0%0.00%
Q1 2019$9,0000.0%10,0000.0%0.00%
Q4 2018$9,0000.0%10,0000.0%0.00%
Q3 2018$9,0000.0%10,0000.0%0.00%
Q2 2018$9,0000.0%10,0000.0%0.00%
Q1 2018$9,000
-50.0%
10,000
-50.0%
0.00%
Q4 2017$18,000
+125.0%
20,000
+233.3%
0.00%
Q1 2016$8,000
-11.1%
6,0000.0%0.00%
Q4 2015$9,0006,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q3 2022
NameSharesValueWeighting ↓
ZAZOVE ASSOCIATES LLC 83,413,000$130,650,0006.13%
AEGON USA Investment Management, LLC 6,000,000$9,368,0002.35%
MACKAY SHIELDS LLC 24,370,000$38,152,0002.07%
INCOME RESEARCH & MANAGEMENT 4,374,000$6,829,0001.11%
KINGDON CAPITAL MANAGEMENT, L.L.C. 20,000$20,347,0000.99%
SHENKMAN CAPITAL MANAGEMENT INC 5,269,000$8,264,0000.82%
Mitsubishi UFJ Securities Holdings Co., Ltd. 325,000$511,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 9,299,000$14,598,0000.47%
ADVENT CAPITAL MANAGEMENT /DE/ 14,543,000$23,021,0000.35%
CSS LLC/IL 3,750,000$5,893,0000.35%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders